-
1
-
-
3543144957
-
Prevention and management of osteoporosis
-
The WHO Scientific Group
-
The WHO Scientific Group. Prevention and management of osteoporosis. World Health Organ Tech Rep Ser 2003; 921: 86-109
-
(2003)
World Health Organ Tech Rep Ser
, vol.921
, pp. 86-109
-
-
-
2
-
-
0033624881
-
2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis
-
2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 2000; 15: 515-21
-
(2000)
J Bone Miner Res
, vol.15
, pp. 515-521
-
-
Shiraki, M.1
Shiraki, Y.2
Aoki, C.3
-
3
-
-
4644274495
-
Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study
-
Ishida Y, Kawai S. Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study. Am J Med 2004; 117: 549-55
-
(2004)
Am J Med
, vol.117
, pp. 549-555
-
-
Ishida, Y.1
Kawai, S.2
-
4
-
-
0035661101
-
Effect of menatetrenone on bone mineral density and incidence of vertebral fractures in postmenopausal women with osteoporosis: A comparison with the effect of etidronate
-
Iwamoto J, Takeda T, Ichimura S. Effect of menatetrenone on bone mineral density and incidence of vertebral fractures in postmenopausal women with osteoporosis: a comparison with the effect of etidronate. J Orthop Sci 2001; 6: 487-92
-
(2001)
J Orthop Sci
, vol.6
, pp. 487-492
-
-
Iwamoto, J.1
Takeda, T.2
Ichimura, S.3
-
5
-
-
44349110678
-
Efficacy of risedronate against hip fracture in patients with neurological diseases: A meta-analysis of randomized controlled trials
-
Iwamoto J, Matsumoto H, Takeda T. Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials. Curr Med Res Opin 2008; 24: 1379-84
-
(2008)
Curr Med Res Opin
, vol.24
, pp. 1379-1384
-
-
Iwamoto, J.1
Matsumoto, H.2
Takeda, T.3
-
6
-
-
23744507892
-
The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: A randomized controlled trial
-
Sato Y, Kanoko T, Satoh K, et al. The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial. Arch Intern Med 2005; 165: 1737-42
-
(2005)
Arch Intern Med
, vol.165
, pp. 1737-1742
-
-
Sato, Y.1
Kanoko, T.2
Satoh, K.3
-
7
-
-
23744484933
-
Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke
-
Sato Y, Iwamoto J, Kanoko T, et al. Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke. Arch Intern Med 2005; 165: 1743-8
-
(2005)
Arch Intern Med
, vol.165
, pp. 1743-1748
-
-
Sato, Y.1
Iwamoto, J.2
Kanoko, T.3
-
8
-
-
14644438517
-
Risedronate therapy for prevention of hip fracture after stroke in elderly women
-
Sato Y, Iwamoto J, Kanoko T, et al. Risedronate therapy for prevention of hip fracture after stroke in elderly women. Neurology 2005; 64: 811-6
-
(2005)
Neurology
, vol.64
, pp. 811-816
-
-
Sato, Y.1
Iwamoto, J.2
Kanoko, T.3
-
9
-
-
34147108671
-
Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease
-
Sato Y, Honda Y, Iwamoto J. Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease. Neurology 2007; 68: 911-5
-
(2007)
Neurology
, vol.68
, pp. 911-915
-
-
Sato, Y.1
Honda, Y.2
Iwamoto, J.3
-
10
-
-
33746931673
-
Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: A randomized controlled trial
-
Sato Y, Iwamoto J, Kanoko T, et al. Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: a randomized controlled trial. Mov Disord 2006; 21: 924-9
-
(2006)
Mov Disord
, vol.21
, pp. 924-929
-
-
Sato, Y.1
Iwamoto, J.2
Kanoko, T.3
-
11
-
-
12344283002
-
Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease
-
Sato Y, Kanoko T, Satoh K, et al. Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease. Bone 2005; 36: 61-8
-
(2005)
Bone
, vol.36
, pp. 61-68
-
-
Sato, Y.1
Kanoko, T.2
Satoh, K.3
-
12
-
-
0036309437
-
Amelioration of osteoporosis by menatetrenone in elderly female Parkinson's disease patients with vitamin D deficiency
-
Sato Y, Honda Y, Kaji M, et al. Amelioration of osteoporosis by menatetrenone in elderly female Parkinson's disease patients with vitamin D deficiency. Bone 2002; 31: 114-8
-
(2002)
Bone
, vol.31
, pp. 114-118
-
-
Sato, Y.1
Honda, Y.2
Kaji, M.3
-
13
-
-
0031719828
-
Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients
-
Sato Y, Honda Y, Kuno H, et al. Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients. Bone 1998; 23: 291-6
-
(1998)
Bone
, vol.23
, pp. 291-296
-
-
Sato, Y.1
Honda, Y.2
Kuno, H.3
-
14
-
-
33745678714
-
Vitamin K and the prevention of fractures: Systematic review and meta-analysis of randomized controlled trials
-
Cockayne S, Adamson J, Lanham-New S, et al. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 2006; 166: 1256-61
-
(2006)
Arch Intern Med
, vol.166
, pp. 1256-1261
-
-
Cockayne, S.1
Adamson, J.2
Lanham-New, S.3
-
15
-
-
85100415918
-
-
Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions 4.2.4. [updated March 2005]. Chichester: John Wiley & Sons Ltd, 2005
-
Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions 4.2.4. [updated March 2005]. Chichester: John Wiley & Sons Ltd, 2005
-
-
-
-
16
-
-
23644432857
-
The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed
-
Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. Clin Epidemiol 2005; 58: 882-93
-
(2005)
Clin Epidemiol
, vol.58
, pp. 882-893
-
-
Deeks, J.J.1
Macaskill, P.2
Irwig, L.3
-
17
-
-
0007062415
-
Clinical evaluation of soft capsule menatetrenone (Ea-0167) in the treatment of osteoporosis: Late phase II dose study
-
in Japanese
-
Orimo H, Fujita T, Onomura T, et al. Clinical evaluation of soft capsule menatetrenone (Ea-0167) in the treatment of osteoporosis: late phase II dose study [in Japanese]. J New Remedies Clinics 1992; 41: 1249-79
-
(1992)
J New Remedies Clinics
, vol.41
, pp. 1249-1279
-
-
Orimo, H.1
Fujita, T.2
Onomura, T.3
-
18
-
-
0024370924
-
Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone
-
Hauschka PV, Lian JB, Cole DEC, et al. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 1989; 69: 990-1047
-
(1989)
Physiol Rev
, vol.69
, pp. 990-1047
-
-
Hauschka, P.V.1
Lian, J.B.2
Cole, D.E.C.3
-
19
-
-
0030614790
-
2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro
-
2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J Bone Miner Res 1997; 12: 431-8
-
(1997)
J Bone Miner Res
, vol.12
, pp. 431-438
-
-
Koshihara, Y.1
Hoshi, K.2
-
22
-
-
0242498469
-
2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR
-
2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem 2003; 278: 43919-27
-
(2003)
J Biol Chem
, vol.278
, pp. 43919-43927
-
-
Tabb, M.M.1
Sun, A.2
Zhou, C.3
-
23
-
-
34250003777
-
Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women
-
Knapen MH, Schurgers LJ, Vermeer C. Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int 2007; 18: 963-72
-
(2007)
Osteoporos Int
, vol.18
, pp. 963-972
-
-
Knapen, M.H.1
Schurgers, L.J.2
Vermeer, C.3
-
24
-
-
0034055429
-
Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women
-
Booth SL, Tucker KL, Chen H, et al. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr 2000; 71: 1201-8
-
(2000)
Am J Clin Nutr
, vol.71
, pp. 1201-1208
-
-
Booth, S.L.1
Tucker, K.L.2
Chen, H.3
-
26
-
-
0027232105
-
Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women
-
Szulc P, Chapuy MC, Meunier PJ, et al. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993; 91: 1769-74
-
(1993)
J Clin Invest
, vol.91
, pp. 1769-1774
-
-
Szulc, P.1
Chapuy, M.C.2
Meunier, P.J.3
-
27
-
-
0029879059
-
Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: A three year follow-up study
-
Szulc P, Chapuy MC, Meunier PJ, et al. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone 1996; 18: 487-8
-
(1996)
Bone
, vol.18
, pp. 487-488
-
-
Szulc, P.1
Chapuy, M.C.2
Meunier, P.J.3
-
28
-
-
0031044021
-
Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: The EPIDOS Study
-
Vergnaud P, Garnero P, Meunier PJ, et al. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 1997; 82: 719-24
-
(1997)
J Clin Endocrinol Metab
, vol.82
, pp. 719-724
-
-
Vergnaud, P.1
Garnero, P.2
Meunier, P.J.3
-
29
-
-
0033696401
-
Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin
-
Luukinen H, Käkönen SM, Pettersson K, et al. Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res 2000; 15: 2473-8
-
(2000)
J Bone Miner Res
, vol.15
, pp. 2473-2478
-
-
Luukinen, H.1
Käkönen, S.M.2
Pettersson, K.3
-
30
-
-
0032919414
-
Vitamin K intake and hip fractures in women: A prospective study
-
Feskanich D, Weber P, Willett WC, et al. Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr 1999; 69: 74-9
-
(1999)
Am J Clin Nutr
, vol.69
, pp. 74-79
-
-
Feskanich, D.1
Weber, P.2
Willett, W.C.3
-
31
-
-
34250305557
-
Is cortical bone hip? What determines cortical bone properties?
-
Epstein S. Is cortical bone hip? What determines cortical bone properties? Bone 2007; 41 Suppl. 1: S3-8
-
(2007)
Bone
, vol.41
, Issue.SUPPL. 1
-
-
Epstein, S.1
-
32
-
-
0001865526
-
Clinical evaluation of Ea-0167 (menatetrenone) in the treatment of osteoporosis: Phase III double-blind multicenter comparative study with alfacalcidol
-
in Japanese
-
Orimo H, Fujita T, Onomura T, et al. Clinical evaluation of Ea-0167 (menatetrenone) in the treatment of osteoporosis: phase III double-blind multicenter comparative study with alfacalcidol [in Japanese]. Clin Eval 1992; 20: 45-100
-
(1992)
Clin Eval
, vol.20
, pp. 45-100
-
-
Orimo, H.1
Fujita, T.2
Onomura, T.3
-
33
-
-
0036138471
-
Changes in the supporting muscles of the fractured hip in elderly women
-
Sato Y, Inose M, Higuchi I, et al. Changes in the supporting muscles of the fractured hip in elderly women. Bone 2002; 30: 325-30
-
(2002)
Bone
, vol.30
, pp. 325-330
-
-
Sato, Y.1
Inose, M.2
Higuchi, I.3
-
35
-
-
18244397439
-
Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials
-
Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005; 293: 2257-64
-
(2005)
JAMA
, vol.293
, pp. 2257-2264
-
-
Bischoff-Ferrari, H.A.1
Willett, W.C.2
Wong, J.B.3
-
36
-
-
0029166250
-
2 (menatetrenone) on bone resorption may be related to its side chain
-
2 (menatetrenone) on bone resorption may be related to its side chain. Bone 1995; 16: 179-84
-
(1995)
Bone
, vol.16
, pp. 179-184
-
-
Hara, K.1
Akiyama, Y.2
Nakamura, T.3
-
37
-
-
0027286666
-
Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro
-
Hara K, Akiyama Y, Tajima T, et al. Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro. J Bone Miner Res 1993; 8: 535-42
-
(1993)
J Bone Miner Res
, vol.8
, pp. 535-542
-
-
Hara, K.1
Akiyama, Y.2
Tajima, T.3
|